Form D · Pharmaceuticals

Centry Pharma, Inc.

Fort Lee, NJ · CIK 0001859637

Offering snapshot reported Oct 29, 2021 · SEC filing

Reported sold
$15.3M
Offering amount: $15.3M
Investors reported
43
Form D · investor count
Minimum accepted
$20K
Reported outside-investor minimum
First sale
May 23, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$7.65M$15.3MJul 19, 2021: $11,280,000.00Jul 19, 2021Oct 29, 2021: $15,299,999.00Oct 29, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$11,280,000 → $15,299,999

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 29, 2021Amendment$15,299,999$4,019,999vs Jul 19, 202143SEC filing
Jul 19, 2021Initial$11,280,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
Not reported

Source: Form D, filed Oct 29, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Uri Ben Or Executive
Ron Bentsur Director, Executive
Kenneth Hoberman Director
Matthew Kaplan Director
James Oliviero Director
Enrique Poradosu Executive
Shay Shemesh Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1 Bridge Plaza Suite 275
Fort Lee, NJ, 07024